FDA approves TNKase for acute ischemic stroke
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Mar 6, 2025
0
0
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Mar 6, 2025
0
0
Hospital-based researchers from Denmark have reported a substantial increase in cardiovascular disease risk among male users of anabolic androgenic steroids (AAS). Long-term health outcomes for AAS users show extreme increases ...
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days after their stroke than ...
Feb 8, 2025
0
0
University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre have revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot retrieval procedure ...
Feb 7, 2025
0
0
For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published ...
Oct 17, 2024
0
0
Stroke related to large vessel occlusion (LVO) is a leading cause of disability and death worldwide. Endovascular therapy (minimally invasive procedures like catheterization done inside the blood vessels) has transformed ...
Sep 26, 2024
0
28
Many patients living in rural areas don't have easy access to specialized or emergency care. When they face conditions like strokes, every minute counts when trying to get them the treatment they need.
Sep 11, 2024
0
0
Despite thrombectomy's high success rate in saving the lives of stroke patients, Medicare is paying lower rates over time for the procedure, according to research presented today at the Society of NeuroInterventional Surgery's ...
Jul 25, 2024
1
0
Research presented at the Society of NeuroInterventional Surgery's (SNIS) 21st Annual Meeting highlights the role of socioeconomic variables and their role in successful recovery after stroke surgery, specifically the impact ...
Jul 22, 2024
0
0
Non-English-speaking patients are less likely to arrive by ambulance when experiencing stroke symptoms and less likely to receive thrombectomy, according to research released today at the Society of NeuroInterventional Surgery's ...
Jul 22, 2024
0
0